| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |